Eur Rev Med Pharmacol Sci 2014; 18 (15): 2237-2239

The impact of pharmacovigilance on drug portfolio management

S. Bucurescu

Neurology at Klinikum Ansbach, Ansbach, Germany. s_bucurescu@yahoo.com

This review examines the influence of pharmacovigilance on drug portfolio. As a result of pharmacovigilance studies, actions are taken by national drug administrations and/or the World Health Organization (WHO) that have a strong impact on drug portfolio management: drug withdrawal from medical practice, discovery of new therapeutic indications, discovery of drug interactions, preference for specific pharmaceutical formulations, discovery of contraindications and change of drug prescription status.

Free PDF Download

To cite this article

S. Bucurescu
The impact of pharmacovigilance on drug portfolio management

Eur Rev Med Pharmacol Sci
Year: 2014
Vol. 18 - N. 15
Pages: 2237-2239

Keywords Related articles:

  1. Hair loss in a female patient after administration of fluoxetine: a case report and review of the literature
  2. Sublingual sufentanil, a new opportunity for the improvement of postoperative pain management in Italy
  3. Stribild: a review of component characteristics and combination drug efficacy
  4. Treatment with icatibant in the management of drug induced angioedema
  5. Impact of epigenetics in the management of cardiovascular disease: a review